Invenire Partners, LP Inotiv, Inc. Call Options Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NOTV
# of Institutions
91Shares Held
6.73MCall Options Held
154KPut Options Held
57.7K-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.74 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny484KShares$807,9390.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN449KShares$750,0950.0% of portfolio
-
Kpp Advisory Services LLC Louisville, KY228KShares$380,4100.68% of portfolio
-
Goldman Sachs Group Inc New York, NY224KShares$373,6290.0% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $42.7M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...